These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19177601)

  • 1. Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2009 Jan; 17(2):930. PubMed ID: 19177601
    [No Abstract]   [Full Text] [Related]  

  • 2. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease" [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902].
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1035. PubMed ID: 19434916
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Bhatt L; Vadnerkar G; Kadam SS
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1897-902. PubMed ID: 17280832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease" [European Journal of Medicinal Chemistry 42 (2006) 885-890].
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2008 Dec; 43(12):2909. PubMed ID: 19172758
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L; Rathi B; Kadam SS
    Eur J Med Chem; 2009 Oct; 44(10):3922-9. PubMed ID: 19442419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
    Sarkate A; Dhaneshwar SS
    World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
    Dhaneshwar SS; Chail M; Patil M; Naqvi S; Vadnerkar G
    Eur J Med Chem; 2009 Jan; 44(1):131-42. PubMed ID: 18472188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macromolecular prodrug of 4-aminosalicylic acid for targeted delivery to inflamed colon.
    Vadnerkar G; Dhaneshwar S
    Curr Drug Discov Technol; 2013 Mar; 10(1):16-24. PubMed ID: 22725691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
    Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
    J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
    J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction notice to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis" [Bioorg. Med. Chem. 19 (2011) 5175-82].
    Bioorg Med Chem; 2015 Jan; 23(1):272. PubMed ID: 25671237
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].
    Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Two novel bioactive glucosinolates from broccoli (Brassica oleracea L. var. italica) florets" [Bioorg. Med. Chem. Lett. 22 (2012) 5555-5558].
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6201. PubMed ID: 24288810
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].
    Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
    Lamie PF
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.